학술논문
Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour location
Document Type
Correspondence
Author
Source
In European Journal of Cancer February 2023 180:85-88
Subject
Language
ISSN
0959-8049